Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey

BACKGROUND: Basal cell carcinoma is the most common skin cancer worldwide. Treatment options include both surgical and topical modalities. Although risk of metastasis is low, basal cell carcinoma can be invasive and infiltrate important underlying structures such as bone or cartilage. While many cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlessinger, Daniel I., Iyengar, Sanjana, Yanes, Arianna F., Lazaroff, Jake M., Godinez-Puig, Victoria, Chen, Brian R., Kurta, Anastasia O., Henley, Jill K., Chiren, Sarah G., Furlan, Karina C., Schmitt, Jochen, Deckert, Stefanie, Poon, Emily, Sobanko, Joseph F., Cartee, Todd V., Alam, Murad, Maher, Ian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654122/
https://www.ncbi.nlm.nih.gov/pubmed/29061190
http://dx.doi.org/10.1186/s13063-017-2244-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654122/
https://www.ncbi.nlm.nih.gov/pubmed/29061190
http://dx.doi.org/10.1186/s13063-017-2244-5

Ejemplares similares